| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |